Insider · CIK 0001704256

Conway Charles

Reports to the SEC for 1 company · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001704256

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−27.6K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−6,000 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−61.9K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−2,398 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−25K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−54K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−5,000 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−41.4K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−295 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−3,084 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−22.4K sh	$148.50	−$3.32M	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−11.5K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−7,500 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−3,000 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−775 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−25.2K sh	—	—	0
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+23K sh	—	—	23,000
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Chief Scientific Officer	AAward	+11.5K sh	—	—	11,500
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,750 sh	—	—	23,935
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,800 sh	$123.86	−$223K	22,135
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,750 sh	—	—	7,500
2021-11-25	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,000 sh	—	—	19,897
2021-11-25	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,000 sh	—	—	3,000
2021-11-23	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$37.54	+$375K	16,012
2021-11-23	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+885 sh	$20.79	+$18.4K	16,897
2021-11-23	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	0
2021-11-23	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−885 sh	—	—	41,727
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Chief Scientific Officer	AAward	+15K sh	—	—	15,000
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+30K sh	—	—	30,000
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,747 sh	$83.38	−$146K	10,012
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,750 sh	—	—	11,759
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,750 sh	—	—	11,250
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,000 sh	—	—	8,639
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,361 sh	$90.14	−$123K	7,278
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,000 sh	—	—	6,000
2020-06-17	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Chief Scientific Officer	SSale	−4,000 sh	$72.15	−$289K	4,009
2019-12-18	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,000 sh	—	—	7,000
2019-12-18	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,361 sh	$52.13	−$70.9K	5,639
2019-12-18	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,000 sh	—	—	9,000
2019-11-25	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Chief Scientific Officer	AAward	+12K sh	—	—	12,000
2019-11-25	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+25K sh	—	—	25,000
2019-06-27	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+6,000 sh	—	—	6,000
2018-11-20	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+65K sh	—	—	65,000
2017-12-07	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+42.6K sh	—	—	42,612
2017-12-07	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+32.6K sh	—	—	32,612
2017-09-05	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+10K sh	—	—	10,000
2017-05-09	Biohaven Pharmaceutical Holding Co Ltd.P Purchase	Chief Scientific Officer	PPurchase	+4,000 sh	$17.00	+$68K	4,000

Recent filings

Accepted (ET)
Oct 34
Conway Charles0001562180-22-006950
SEC(opens sec.gov)
Jan 74
Conway Charles0001562180-22-000355
SEC(opens sec.gov)

Companies

Biohaven Pharmaceutical Holding Co Ltd.Chief Scientific Officer

Address

C/O BIOHAVEN PHARMACEUTICALS, INC. 234 CHURCH STREET

NEW HAVEN, CT, 06510